Search

01/05/2023 Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial
Conen, D, Popova, E, Wang, MK, Chan, MTV, Landoni, G, Reimer, C, Srinathan, SK, Cata, JP, McLean, SR, Reyes, JCT, Grande, AM, Tallada, AG, Sessler, DI, Fleischmann, E, Maziak, DE, Kabon, B, Voltolini, L, Gutierrez-Soriano, L, Tandon, V, DuMerton, D, Kidane, B, Rajaram, R, Shargall, Y, Neary, JD, Wells, JR, McIntyre, WF, Blum, S, Ofori, SN, Vincent, J, Xu, LZ, Li, ZR, Healey, JS, Garg, AX, Devereaux, PJ, COP-AF Investigators. Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial. AMERICAN HEART JOURNAL. 2023; 259DOI:10.1016/j.ahj.2023.01.018. PMID:36754105. IF:3.700(Q1/3D).
27/04/2023 Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies
Saiz, LC, Leache, L, Gutierrez-Valencia, M, Erviti, J, Reyes, MXR. Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies. Therapeutic Advances in Hematology. 2023; 14DOI:10.1177/20406207231168211. PMID:37138698. IF:3.400(Q2/3D).
10/04/2023 Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?
Annesi-Maesano, I, Cecchi, L, Biagioni, B, Chung, KF, Clot, B, Coen, MC, Amato, GD, Damialis, A, Dominguez-Ortega, J, Galan, C, Gilles, S, Holgate, S, Jeebhay, M, Kazadzis, S, Papadopoulos, NG, Quirce, S, Sastre, J, Tummon, F, Traidl-Hoffmann, C, Walusiak-Skorupa, J, Alonso-Coello, P, Canelo-Aybar, C, Cantero-Fortiz, Y, Rigau, D, Salazar, J, Verdugo-Paiva, F, Jutel, M, Akdis, CA, Agache, I. Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?. ALLERGY. 2023; 78(8)DOI:10.1111/all.15724. PMID:36961370. IF:12.600(Q1/1D).
04/04/2023 ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I, Torres, A, Nagavci, B, Aliberti, S, Antonelli, M, Bassetti, M, Bos, L, Chalmers, J, Derde, L, de Waele, J, Garnacho-Montero, J, Kollef, M, Luna, C, Menendez, R, Niederman, M, Ponomarev, D, Restrepo, M, Rigau, D, Schultz, M, Weiss, E, Welte, T, Wunderink, R. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. INTENSIVE CARE MEDICINE. 2023; 49(6)DOI:10.1007/s00134-023-07033-8. PMID:37012484. IF:29.600(Q1/1D).